Polso (formerly ChroniSense Medical)
About Polso (formerly ChroniSense Medical)
Polso, formerly ChroniSense Medical, is a digital health company focused on transforming remote patient care and advancing clinical research. Their core offering is a remote patient monitoring (RPM) platform that combines a medical-grade, wrist-worn multi-sensor device with a patient mobile application and a cloud-based clinician dashboard. This system is designed to continuously monitor multiple vital signs, including pulse rate, blood oxygen level, respiratory rate, and blood pressure, with clinically validated accuracy. The platform emphasizes signal processing and data science to deliver medical-grade monitoring for chronic disease management and supports clinical validation and decentralized clinical trials.
For physicians, Polso’s solution aims to empower patients with a better understanding of their biometric data while providing healthcare providers and clinical researchers with easy, remote access to multiple vital signs, ultimately improving patient care and outcomes. The company’s technology has achieved regulatory clearance for selected vital-sign measurements, with initial FDA 510(k) clearance for monitoring blood oxygen saturation (SpO2), pulse rate, and respiration rate. They are also developing additional vital sign monitoring parameters, including blood pressure via IP-protected radial artery signal acquisition. Polso’s platform is built to lay the foundation for future AI-based predictive insights.
Focus Areas
Business Intelligence
| Key Investors | Rainbow Medical, Vinno Capital |
| Partnerships | Milton Keynes University Hospital (for a clinical validation study) |
| Technology | Polso CONNECT™ is a multi-sensor wireless wrist monitor, mobile application, and cloud-based platform. It leverages robust radial artery signals for medical-grade vital sign acquisition and is building the foundation for future AI-based predictive insights. |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Polso offers a reliable and easy-to-use remote patient monitoring solution for chronic care management and decentralized clinical trials. The medical-grade data, derived from robust radial artery biosignals, provides trustworthy insights into patient health. The platform's ability to monitor multiple vital signs through a comfortable wrist-worn device can enhance patient compliance and engagement. The cloud-based platform allows for remote review of patient data, facilitating proactive care and potentially reducing healthcare costs associated with chronic conditions. The ongoing development of additional parameters like blood pressure monitoring further expands its potential utility in managing complex patients.
While the core Polso CONNECTu2122 platform integrates a wearable device, mobile app, and cloud platform, specific information regarding integrations with existing Electronic Health Record (EHR) systems or other healthcare IT infrastructure is not explicitly detailed in the provided information. However, their expertise in digital health platform development (mobile + cloud) and regulatory submissions suggests a capability for such integrations.
Products by Polso (formerly ChroniSense Medical)
Reviews & Opinions
Videos
News, demos, and interviews about Polso (formerly ChroniSense Medical).
Videos load interactively. If none appear, search YouTube for Polso (formerly ChroniSense Medical) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]